Reshoring Pharmaceutical Production: Are Buy America Laws Enough?
By Kenneth Rapoza, Industry Analyst, CPA President Trump and many members of Congress are talking about reshoring pharmaceutical production. We look at the benefits of reshoring in health security, national security, and the economy. We also look at challenges to this objective, including the shortcomings in current Buy American and related legislation, the vague definitions…